Key facts

Active Substance
Sirolimus
Therapeutic area
Other
Decision number
P/0395/2017
PIP number
EMEA-002213-PIP01-17
Pharmaceutical form(s)
Implant
Condition(s) / indication(s)
Prevention of arteriovenous access dysfunction
Route(s) of administration
Implantation
Contact for public enquiries

Vascular Therapies, Inc.

Tel. +1 2012668310
E-mail: david@vasculartx.com

Decision type
W: decision granting a waiver in all age groups for all conditions or indications
Decision date

Decision

P/0395/2017: EMA decision of 19 December 2017 on the granting of a product specific waiver for sirolimus (EMEA-002213-PIP01-17)

How useful do you find this page?